CLINICAL_TRIALS
trial_result
· 2022-06-23
Clinical Trial Update: Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity [Phase 2]
Summary
Phase 2 pilot trial evaluating liraglutide 3.0 mg for weight loss and gastric function in obesity has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael Camilleri, MD | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2022-06-23